These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11787852)

  • 1. Expression of somatostatin receptor types 2, 3 and 5 in biopsies and surgical specimens of human lung tumours. Correlation with preoperative octreotide scintigraphy.
    Papotti M; Croce S; Bellò M; Bongiovanni M; Allìa E; Schindler M; Bussolati G
    Virchows Arch; 2001 Dec; 439(6):787-97. PubMed ID: 11787852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlative immunohistochemical and reverse transcriptase polymerase chain reaction analysis of somatostatin receptor type 2 in neuroendocrine tumors of the lung.
    Papotti M; Croce S; Macrì L; Funaro A; Pecchioni C; Schindler M; Bussolati G
    Diagn Mol Pathol; 2000 Mar; 9(1):47-57. PubMed ID: 10718213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin receptors in malignant lymphomas: targets for radiotherapy?
    Dalm VA; Hofland LJ; Mooy CM; Waaijers MA; van Koetsveld PM; Langerak AW; Staal FT; van der Lely AJ; Lamberts SW; van Hagen MP
    J Nucl Med; 2004 Jan; 45(1):8-16. PubMed ID: 14734660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin receptors 2 and 5 are the major somatostatin receptors in insulinomas: an in vivo and in vitro study.
    Bertherat J; Tenenbaum F; Perlemoine K; Videau C; Alberini JL; Richard B; Dousset B; Bertagna X; Epelbaum J
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5353-60. PubMed ID: 14602773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro expression of somatostatin receptors in two human thymomas with similar clinical presentation and different histological features.
    Ferone D; Kwekkeboom DJ; Pivonello R; Bogers ADColao A; Lamberts SW; van Hagen PM; Hofland LJ
    J Endocrinol Invest; 2001; 24(7):522-8. PubMed ID: 11508787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin receptor subtypes in human pheochromocytoma: subcellular expression pattern and functional relevance for octreotide scintigraphy.
    Mundschenk J; Unger N; Schulz S; Höllt V; Schulz S; Steinke R; Lehnert H
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5150-7. PubMed ID: 14602742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crucial role for somatostatin receptor subtype 2 in determining the uptake of [111In-DTPA-D-Phe1]octreotide in somatostatin receptor-positive organs.
    Hofland LJ; Lamberts SW; van Hagen PM; Reubi JC; Schaeffer J; Waaijers M; van Koetsveld PM; Srinivasan A; Krenning EP; Breeman WA
    J Nucl Med; 2003 Aug; 44(8):1315-21. PubMed ID: 12902423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative somatostatin receptor scintigraphy using in-111-DOTA-lanreotide and in-111-DOTA-Tyr3-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy.
    Virgolini I; Patri P; Novotny C; Traub T; Leimer M; Füger B; Li SR; Angelberger P; Raderer M; Wogritsch S; Kurtaran A; Kletter K; Dudczak R
    Ann Oncol; 2001; 12 Suppl 2():S41-5. PubMed ID: 11762351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2.
    John M; Meyerhof W; Richter D; Waser B; Schaer JC; Scherübl H; Boese-Landgraf J; Neuhaus P; Ziske C; Mölling K; Riecken EO; Reubi JC; Wiedenmann B
    Gut; 1996 Jan; 38(1):33-9. PubMed ID: 8566856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin sst2 receptor knock-out mice: localisation of sst1-5 receptor mRNA and binding in mouse brain by semi-quantitative RT-PCR, in situ hybridisation histochemistry and receptor autoradiography.
    Hannon JP; Petrucci C; Fehlmann D; Viollet C; Epelbaum J; Hoyer D
    Neuropharmacology; 2002 Mar; 42(3):396-413. PubMed ID: 11897118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution and functional significance of somatostatin receptors in malignant melanoma.
    Lum SS; Fletcher WS; O'Dorisio MS; Nance RW; Pommier RF; Caprara M
    World J Surg; 2001 Apr; 25(4):407-12. PubMed ID: 11344389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of somatostatin receptor scintigraphic imaging (octreoscan) in esthesioneuroblastoma: a case study and survey of somatostatin receptor subtype expression.
    Rostomily RC; Elias M; Deng M; Elias P; Born DE; Muballe D; Silbergeld DL; Futran N; Weymuller EA; Mankoff DA; Eary J
    Head Neck; 2006 Apr; 28(4):305-12. PubMed ID: 16470879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with indium-111 and yttrium-90-labeled somatostatin analogs.
    Virgolini I; Traub T; Novotny C; Leimer M; Füger B; Li SR; Patri P; Pangerl T; Angelberger P; Raderer M; Burggasser G; Andreae F; Kurtaran A; Dudczak R
    Curr Pharm Des; 2002; 8(20):1781-807. PubMed ID: 12171531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical detection of somatostatin receptor types 1-5 in medullary carcinoma of the thyroid.
    Papotti M; Kumar U; Volante M; Pecchioni C; Patel YC
    Clin Endocrinol (Oxf); 2001 May; 54(5):641-9. PubMed ID: 11380495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin receptor genes are expressed in lymphocytes from retroorbital tissues in Graves' disease.
    Pasquali D; Notaro A; Bonavolonta' G; Vassallo P; Bellastella A; Sinisi AA
    J Clin Endocrinol Metab; 2002 Nov; 87(11):5125-9. PubMed ID: 12414882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internalized somatostatin receptor subtype 2 in neuroendocrine tumors of octreotide-treated patients.
    Reubi JC; Waser B; Cescato R; Gloor B; Stettler C; Christ E
    J Clin Endocrinol Metab; 2010 May; 95(5):2343-50. PubMed ID: 20228164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis.
    Papotti M; Bongiovanni M; Volante M; Allìa E; Landolfi S; Helboe L; Schindler M; Cole SL; Bussolati G
    Virchows Arch; 2002 May; 440(5):461-75. PubMed ID: 12021920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin receptor 2A expression in choroidal neovascularization secondary to age-related macular degeneration.
    Lambooij AC; Kuijpers RW; van Lichtenauer-Kaligis EG; Kliffen M; Baarsma GS; van Hagen PM; Mooy CM
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2329-35. PubMed ID: 10892880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression of somatostatin receptor subtypes SSTR2a, SSTR3 and SSTR5 in peripheral blood of neuroendocrine lung cancer affected patients.
    Muscarella LA; D'Alessandro V; la Torre A; Copetti M; De Cata A; Parrella P; Sperandeo M; Pellegrini F; Frusciante V; Maiello E; Merla G; Fazio VM; Vendemiale G
    Cell Oncol (Dordr); 2011 Oct; 34(5):435-41. PubMed ID: 21503779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of somatostatin receptor 2 immunohistochemical expression with [111In]-DTPA octreotide scintigraphy and [68Ga]-DOTATOC PET/CT in neuroendocrine tumors.
    Müssig K; Oksüz MO; Dudziak K; Ueberberg B; Wehrmann M; Horger M; Schulz S; Häring HU; Pfannenberg C; Bares R; Gallwitz B; Petersenn S
    Horm Metab Res; 2010 Jul; 42(8):599-606. PubMed ID: 20422506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.